Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine 06 Oct 2020 News
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate 15 Sep 2020 News
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine 30 Jul 2020 News
Sanofi and Regeneron provide update on Kevzara Phase 3 U.S. trial in COVID-19 patients 07 Jul 2020 News
Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas 24 Jun 2020 News
Sanofi invests to make France its world class center of excellence in vaccine research and production 16 Jun 2020 News
Transatlantic tensions over access to COVID-19 vaccines mount after Sanofi CEO says US is first in queue Transatlantic tensions over access to COVID-19 vaccines mount after Sanofi CEO says US is first in queue ‘Equal access for all is non-negotiable’ says French prime minister in response 15 May 2020 News
Viewpoint: Now is the time to strengthen Europe’s ability to respond to health threats Viewpoint: Now is the time to strengthen Europe’s ability to respond to health threats The urgent need is to contain the pandemic, but COVID-19 also highlights the need for action in the longer term to ensure Europe’s health sovereignty 29 Apr 2020 Health
Sanofi and Regeneron provide update on U.S. Phase 2/3 trial in hospitalized COVID-19 patients 28 Apr 2020 News